Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 367.49 | N/A |
| PEG Ratio (TTM) | 3.67 | N/A |
| P/S Ratio (TTM) | 0.58 | N/A |
| P/B Ratio (TTM) | 16.24 | N/A |
| P/FCF Ratio (TTM) | 24.63 | N/A |
| Price to 5YR AVG Earnings Ratio | -48.18 | N/A |
| Price to 5YR AVG FCF Ratio | 140.82 | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.53% | N/A |
| ROE (TTM) | 4.66% | N/A |
| Net Profit Margin (TTM) | 0.16% | N/A |
| ROIC 5YR AVG | -8.12% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.78% | 46.12% | 25.15% |
| Revenue | 5.33% | -9.19% | -7.48% |
| Net Income | 1.22% | 46.00% | 24.18% |
| Cash Flow | 7.45% | 57.94% | 70.33% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.87 | N/A |
| Quick Ratio (TTM) | 1.87 | N/A |
| D/E Ratio (TTM) | 3.20 | N/A |
| Interest Coverage (TTM) | 2.54 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 5.28 | N/A |
| LTL to 5YR AVG FCF | 25.58 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.99% | N/A |